Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sen. Kamala Harris during a campaign event on Aug. 27. Photo: Michael A. McCoy/Getty Images

Democratic vice presidential nominee Sen. Kamala Harris told CNN in an interview airing Sunday she "would not trust" President Trump "about the efficacy and the reliability" of a coronavirus vaccine if approved before November's election.

Driving the news: The CDC has requested governors "urgently" speed up their permit applications so vaccine distribution sites are operational by early November. The Trump administration has this week pushed back on questions of political interference in vaccine development.

A tweet previously embedded here has been deleted or was tweeted from an account that has been suspended or deleted.
  • White House press secretary Kayleigh McEnany said Thursday, "No one is pressuring the FDA to do anything."

What she's saying: "It would have to be a credible source of information that talks about the efficacy and the reliability of whatever he's talking about," Harris said in her "State of the Union" interview, expressing concern that health officials might not have final approval on a vaccine.

  • "If past is prologue that they will not," she added.
  • "They’ll be muzzled, they’ll be suppressed, they will be sidelined because he’s looking at an election coming up in less than 60 days, and he’s grasping for whatever he can get to pretend that he’s been a leader on this issue when he’s not."

Of note: NIAID director Anthony Fauci told CNN on Thursday that if he saw interference, he would "call it out."

  • Fauci added that he's sure a vaccine "would not be approved for the American public unless it was indeed both safe and effective."

Go deeper: The scramble to prepare for a coronavirus vaccine

Go deeper

How the U.S. might distribute a coronavirus vaccine

Illustration: Annelise Capossela/Axios

Now that there are glimmers of hope for a coronavirus vaccine, governments, NGOs and others are hashing out plans for how vaccines could be distributed once they are available — and deciding who will get them first.

Why it matters: Potential game-changer vaccines will be sought after by everyone from global powers to local providers. After securing supplies, part of America's plan is to tap into its military know-how to distribute those COVID-19 vaccines.

In photos: First coronavirus vaccines administered in the U.S.

The first doses of Pfizer's long-awaited coronavirus vaccine were distributed in the U.S. on Monday.

The state of play: Vaccines will first go to frontline health care workers followed by older and vulnerable populations. The distribution of Pfizer vaccine marks the beginning of a possible end of the coronavirus pandemic, and may soon be followed by a rollout of vaccines from Moderna and AstraZeneca.